Market Overview
The North America biopharmaceuticals contract manufacturing market is poised for remarkable expansion, with its valuation expected to rise from USD 5,483.81 million in 2023 to USD 19,927.57 million by 2032, registering an impressive CAGR of 15.42% during the forecast period. This substantial growth reflects the increasing reliance of biopharmaceutical companies on contract manufacturing organizations (CMOs) to streamline production, reduce time-to-market, and lower operational cos